Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat adults with Cushing's disease who cannot undergo pituitary surgery or whose surgery was unsuccessful. Cushing's disease causes excessive cortisol production, leading to various symptoms such as weight gain, skin thinning, bone pain, and mood changes. Isturisa works by reducing cortisol levels, helping to manage symptoms and restore hormonal balance.